Effectiveness and Tolerability of Once-Weekly GLP-1 Receptor Agonists in Clinical Practice: A Focus on Switching Between Once-Weekly Molecules in Type 2 Diabetes

Academic Article

Publication Date:

2022

abstract:

This study aims to evaluate the effectiveness and tolerability of once-weekly glucagon-like peptide receptor agonists (OW GLP-1RAs) and to assess the clinical benefits of switching from one GLP-1RA to another (switchers) in a routine clinical setting.

Iris type:

1.1 Articolo in rivista

Keywords:

GLP-1 receptor agonists; dulaglutide; effectiveness; once-weekly exenatide; once-weekly semaglutide; real-world evidence; type 2 diabetes mellitus; Body Weight; Cohort Studies; Drug Administration Schedule; Glucagon-Like Peptide-1 Receptor; Glycated Hemoglobin A; Humans; Hypoglycemic Agents; Retrospective Studies; Diabetes Mellitus, Type 2

List of contributors: